Moderna Inc. buy UBS Group AG
Start price
26.06.23
/
50%
€111.22
Target price
26.06.24
€174.90
Performance (%)
2.48%
End price
27.06.24
€113.98
Summary
This prediction ended on 27.06.24 with a price of €113.98. The BUY prediction by UBS_Group_AG finished with a performance of 2.48%. UBS_Group_AG has a follow-up prediction for Moderna Inc. where he still thinks Moderna Inc. is a Buy. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Moderna Inc. | 18.109% | 18.109% | 140.252% | -40.462% |
| iShares Core DAX® | 0.881% | 5.632% | 8.477% | 63.917% |
| iShares Nasdaq 100 | 2.390% | 1.571% | 28.412% | 91.986% |
| iShares Nikkei 225® | 4.269% | 2.521% | 50.984% | 83.957% |
| iShares S&P 500 | 1.171% | 2.545% | 23.603% | 71.357% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating. They now have a $191.00 price target on the stock, down previously from $221.00.
Ratings data for MRNA provided by MarketBeat
In the thread Trading Moderna Inc.
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten